Daiwa Securities Group Inc. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,003,000
-80.9%
1,000,000
-80.0%
0.01%
-80.0%
Q2 2022$5,261,000
+373.1%
5,000,000
+400.0%
0.04%
+471.4%
Q4 2021$1,112,0001,000,0000.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opti Capital Management, LP 5,300,000$6,265,0000.59%
SHENKMAN CAPITAL MANAGEMENT INC 4,457,000$5,272,0000.40%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,416,000$12,314,0000.28%
AQR Arbitrage LLC 7,700,000$9,119,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 21,227,000$25,018,0000.22%
LINDEN ADVISORS LP 26,849,000$31,752,0000.19%
HBK INVESTMENTS L P 10,000,000$11,822,0000.05%
Calamos Advisors LLC 7,500,000$8,910,0000.04%
Jefferies Group LLC 3,245,000$3,856,6770.03%
CAPSTONE INVESTMENT ADVISORS, LLC 9,700,000$11,487,0000.02%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders